Healthcare and Venom Research
Healthcare and Venom Research is a research topic within Pharmacology. Science Explorer counts 29k research works in it since 1950. 9.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the therapeutic potential of bee venom and its constituent compounds, particularly melittin, in various medical applications. The research covers anti-cancer effects, pain relief, anti-inflammatory properties, apoptosis induction, and potential use in conditions such as rheumatoid arthritis and neurodegenerative diseases. Additionally, it investigates the use of bee venom in acupuncture and its immunomodulatory effects.
- Bee Venom
- Melittin
- Anti-cancer
- Pain Relief
- Anti-inflammatory
- Apoptosis Induction
- Rheumatoid Arthritis
- Neuroprotective Effects
- Acupuncture
- Immunomodulation
- Research works
- 29k fractional, since 1950
- In the world top 10%
- 2.9k per year above
- Top-10% rate
- 9.7% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +19% the tick is no change
- Largest producer
China
34% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Healthcare and Venom Research research?
By volume, China and South Korea publish the most (1k and 347 works in 2022-now).
By volume, 2022-now
- 1
China 1k works
- 2
South Korea 347 works
- 3
India 333 works
- 4
United States 324 works
- 5
Indonesia 269 works
- 6
Türkiye 177 works
- 7
Egypt 157 works
- 8
Brazil 154 works
- 9
Iran 126 works
- 10
Japan 108 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Healthcare and Venom Research research?
By volume in 2022-now, Kyung Hee University publishes the most Healthcare and Venom Research research, followed by Beijing University of Chinese Medicine and Shaanxi University of Chinese Medicine.
By volume, 2022-now
- 1
Kyung Hee University
South Korea 39 works
- 2
Beijing University of Chinese Medicine
China 39 works
- 3
Shaanxi University of Chinese Medicine
China 34 works
- 4
Shanghai University of Traditional Chinese Medicine
China 30 works
- 5
Chinese Academy of Medical Sciences & Peking Union Medical College
China 26 works
- 6
Dunsan Korean Medicine Hospital
South Korea 24 works
- 7
Guangzhou University of Chinese Medicine
China 20 works
- 8
Chengdu University of Traditional Chinese Medicine
China 19 works
- 9
Cairo University
Egypt 18 works
- 10
Jaseng Hospital of Korean Medicine
South Korea 17 works
Who are the leading researchers in Healthcare and Venom Research?
The most-cited researchers publishing on Healthcare and Venom Research include Jun Wang, Gordon Henry Guyatt and Wei Huang.
- 1
Jun Wang
China 340k citations
- 2
Gordon Henry Guyatt
Canada 315k citations
- 3
Wei Huang
China 267k citations
- 4
Amirhossein Sahebkar
Iran 258k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Healthcare and Venom Research research done?
The largest centres of Healthcare and Venom Research research in 2022-now are Beijing (China), Seoul (South Korea), Shanghai (China) and Daejeon (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Xianyang and Daejeon.
Largest cities, 2022-now
Where it is the local speciality
- XianyangCN · 46.1 works51×
- DaejeonKR · 63.3 works8.8×
Location quotient: how much more of its research is in Healthcare and Venom Research than the world average.
Where is the best place to study Healthcare and Venom Research?
Among universities, judged by research, Kyung Hee University, Beijing University of Chinese Medicine and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Healthcare and Venom Research, country by countryIs Healthcare and Venom Research research growing?
Output in 2022-2025 was 19% higher than in 2018-2021, peaking in 2013. The fastest-growing topics are Healthcare and Venom Research.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Healthcare and Venom Research as a percentage of every work published that year, 0.020% in 2024.
Fractional works of Healthcare and Venom Research over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Healthcare and Venom Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.